ER-NE T>C polymorphism in ESR1 gene promoter and increased risk of breast cancer
-
Published:2023-12-01
Issue:4
Volume:16
Page:21-33
-
ISSN:1017-0707
-
Container-title:Journal of Breast Disease
-
language:fa
-
Short-container-title:ijbd
Author:
Alvandi Ashiani SheidaORCID, Mohamadynejad ParisaORCID
Publisher
Apex Publishing
Reference26 articles.
1. 1. Allahqoli L, Mazidimoradi A, Momenimovahed Z, Rahmani A, Hakimi S, Tiznobaik A, et al. The global incidence, mortality, and burden of breast cancer in 2019: correlation with smoking, drinking, and drug use. Frontiers in Oncology. 2022;12:921015. 2. 2. Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A,et al. Risk factors for breast cancer in women: an update review. Medical Oncology. 2022;39(12):197. 3. 3. Al-Eitan LN, Rababa’h DM, Alghamdi MA, Khasawneh RH. Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC cancer. 2019;19(1):1-0. 4. 4. Tan SC, Low TY, Mohamad Hanif EA, Sharzehan MA, Kord-Varkaneh H, Islam MA. The rs9340799 polymorphism of the e strogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility. Scientific Reports. 2021;11(1):18619. 5. 5. Figtree GA, Noonan JE, Bhindi R, Collins P. Estrogen receptor polymorphisms: significance to human physiology, disease and therapy. Recent Patents on DNA & Gene Sequences (Discontinued). 2009;3(3):164-71.
|
|